Takeda Pharmaceutical Company Limited (TAK)
Growth
Revenue 5Y0.60%
Revenue 3Y1.56%
EPS 5Y0.02%
EPS 3Y9.07%
Dividend 5Y0.02%
Dividend 3Y6.89%
Capital Efficiency
ROIC3.03%
ROE3.55%
ROA1.46%
ROTA2.05%
Capital Structure
Market Cap48.87B
EV3.99T
Cash798.14B
Current Ratio1.15
Debt/Equity0.54
Net Debt/EBITDA3.81
TAK
Income Statement
Select a metric from the list below to chart it
Mar '00
Mar '04
Mar '08
Mar '12
Mar '16
Mar '20
Income Statement | Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13,172.8 | 13,843.5 | 14,073.6 | 13,487.1 | 13,786.7 | 16,330.6 | 25,627.7 | 24,900.6 | 27,791.0 | 29,195.3 | |
Revenue % Chg. | 8.6% | 5.1% | 1.7% | -4.2% | 2.2% | 18.5% | 56.9% | -2.8% | 11.6% | 10.2% | |
Cost of Revenue | 3,817.6 | 4,056.8 | 4,169.1 | 4,350.9 | 3,861.6 | 5,136.9 | 8,485.7 | 7,742.4 | 8,618.8 | 9,251.6 | |
Cost of Revenue % Chg. | 9.5% | 6.3% | 2.8% | 4.4% | -11.2% | 33.0% | 65.2% | -8.8% | 11.3% | 16.1% | |
Gross Profit | 9,355.2 | 9,786.7 | 9,904.6 | 9,136.2 | 9,925.1 | 11,193.7 | 17,142.0 | 17,158.2 | 19,172.3 | 19,943.8 | |
Gross Profit % Chg. | 8.3% | 4.6% | 1.2% | -7.8% | 8.6% | 12.8% | 53.1% | 0.1% | 11.7% | 7.7% | |
Gross Profit Margin | 71.0% | 70.7% | 70.4% | 67.7% | 72.0% | 68.5% | 66.9% | 68.9% | 69.0% | 68.3% | |
Gross Profit Margin % Chg. | -0.3% | -0.5% | -0.5% | -3.7% | 6.3% | -4.8% | -2.4% | 3.0% | 0.1% | -2.3% | |
R&D Expenses | 2,659.6 | 2,975.3 | 2,693.7 | 2,431.8 | 2,534.1 | 2,867.9 | 3,834.1 | 3,549.5 | 4,096.5 | 4,436.6 | |
R&D Expenses % Chg. | - | 11.9% | -9.5% | -9.7% | 4.2% | 13.2% | 33.7% | -7.4% | 15.4% | 17.5% | |
Selling, General, & Admin Expenses | - | - | - | - | - | - | - | - | 6,901.9 | 7,278.5 | |
Selling, General, & Admin Expenses % Chg. | - | - | - | - | - | - | - | - | - | 5.2% | |
Other Expenses | 5,611.1 | 7,817.9 | 6,192.2 | 5,490.7 | 5,508.2 | 7,077.2 | 11,168.8 | 10,974.4 | 4,585.4 | 5,349.1 | |
Other Expenses % Chg. | - | 39.3% | -20.8% | -11.3% | 0.3% | 28.5% | 57.8% | -1.7% | -58.2% | 28.3% | |
Operating Income | 1,084.5 | -1,006.5 | 1,018.7 | 1,213.7 | 1,882.8 | 1,596.0 | 781.9 | 3,965.6 | 3,588.5 | 2,879.7 | |
Operating Income % Chg. | 13.7% | - | - | 19.1% | 55.1% | -15.2% | -51.0% | 407.2% | -9.5% | -42.2% | |
Operating Income Margin | 8.2% | -7.3% | 7.2% | 9.0% | 13.7% | 9.8% | 3.1% | 15.9% | 12.9% | 9.9% | |
Operating Income Margin % Chg. | 4.7% | - | - | 24.3% | 51.8% | -28.4% | -68.8% | 422.0% | -18.9% | -47.5% | |
Total Other Income/Expenses Net | 152.4 | -126.0 | -80.1 | -97.5 | -191.4 | -857.1 | -1,254.9 | -1,113.8 | -1,232.4 | -1,025.1 | |
Total Other Income/Expenses Net % Chg. | 171.8% | - | 36.4% | 21.7% | 96.3% | 347.7% | 46.4% | 11.2% | 10.7% | 14.9% | |
Income Before Tax | 1,236.9 | -1,132.5 | 938.6 | 1,116.2 | 1,691.3 | 738.9 | -473.1 | 2,851.8 | 2,356.0 | 1,854.6 | |
Income Before Tax % Chg. | 22.5% | - | - | 18.9% | 51.5% | -56.3% | - | - | -17.4% | -54.6% | |
Income Before Tax Margin | 9.4% | -8.2% | 6.7% | 8.3% | 12.3% | 4.5% | -1.8% | 11.5% | 8.5% | 6.4% | |
Income Before Tax Margin % Chg. | 12.7% | - | - | 24.1% | 48.2% | -63.1% | - | - | -26.0% | -58.9% | |
Income Tax Expense | 383.8 | -18.7 | 288.6 | 216.7 | 237.5 | -109.9 | -818.0 | -77.4 | 563.8 | 194.4 | |
Income Tax Expense % Chg. | - | - | - | -24.9% | 9.6% | - | 644.0% | 90.5% | - | -51.8% | |
Net Income | 830.5 | -1,135.1 | 624.2 | 895.0 | 1,455.2 | 849.7 | 344.5 | 2,927.9 | 1,791.4 | 1,659.9 | |
Net Income % Chg. | -18.7% | - | - | 43.4% | 62.6% | -41.6% | -59.5% | 749.9% | -38.8% | -54.9% | |
Net Income Margin | 6.3% | -8.2% | 4.4% | 6.6% | 10.6% | 5.2% | 1.3% | 11.8% | 6.4% | 5.7% | |
Net Income Margin % Chg. | -25.2% | - | - | 49.6% | 59.1% | -50.7% | -74.2% | 774.7% | -45.2% | -59.1% | |
Weighted Avg. Shares Out | 1,578.9 | 1,572.8 | 1,567.9 | 1,562.2 | 1,561.6 | 1,923.0 | 3,114.4 | 3,124.0 | 3,124.0 | 3,130.3 | |
Weighted Avg. Shares Out % Chg. | 0.0% | -0.4% | -0.3% | -0.4% | -0.0% | 23.1% | 62.0% | 0.3% | - | -0.1% | |
EPS | 0.5 | -0.7 | 0.4 | 0.6 | 0.9 | 0.4 | 0.1 | 0.9 | 0.6 | 0.5 | |
EPS % Chg. | -18.7% | - | - | 43.9% | 62.7% | -52.6% | -75.0% | 747.3% | -38.8% | -54.9% | |
Weighted Avg. Shares Out Dil | 1,580.7 | 1,572.8 | 1,576.4 | 1,571.7 | 1,573.4 | 1,933.8 | 3,132.4 | 3,147.1 | 3,147.1 | 3,149.8 | |
Weighted Avg. Shares Out Dil % Chg. | 0.1% | -0.5% | 0.2% | -0.3% | 0.1% | 22.9% | 62.0% | 0.5% | - | -0.1% | |
EPS Diluted | 0.5 | -0.7 | 0.4 | 0.6 | 0.9 | 0.4 | 0.1 | 0.9 | 0.6 | 0.5 | |
EPS Diluted % Chg. | -18.8% | - | - | 43.8% | 62.4% | -52.5% | -75.0% | 745.9% | -38.8% | -54.9% | |
Interest Income | 383.9 | 119.6 | 168.5 | 95.6 | 307.9 | 51.5 | 87.2 | 13.9 | 184.5 | 408.8 | |
Interest Income % Chg. | 202.4% | -68.8% | 40.9% | -43.3% | 222.2% | -83.3% | 69.2% | -84.1% | 1230.7% | 175.3% | |
Interest Expense | 239.2 | 256.0 | 248.6 | 181.0 | 248.6 | 375.0 | 1,160.3 | 1,018.6 | 1,297.3 | 1,331.1 | |
Interest Expense % Chg. | 824.5% | 7.0% | -2.9% | -27.2% | 37.3% | 50.8% | 209.4% | -12.2% | 27.4% | 36.7% | |
EBIT | 1,381.6 | -1,268.9 | 858.5 | 1,030.7 | 1,750.6 | 415.5 | -1,546.2 | 1,847.1 | 1,243.3 | 932.3 | |
EBIT % Chg. | 24.3% | - | - | 20.1% | 69.8% | -76.3% | - | - | -32.7% | -71.4% | |
EBIT Margin | 10.5% | -9.2% | 6.1% | 7.6% | 12.7% | 2.5% | -6.0% | 7.4% | 4.5% | 3.2% | |
EBIT Margin % Chg. | 14.5% | - | - | 25.3% | 66.2% | -80.0% | - | - | -39.7% | -74.1% | |
Depreciation & Amortization | 1,679.9 | 2,032.0 | 1,537.0 | 1,734.8 | 1,418.2 | 2,121.5 | 4,544.7 | 4,358.0 | 4,540.9 | 4,871.9 | |
Depreciation & Amortization % Chg. | 7.3% | 21.0% | -24.4% | 12.9% | -18.3% | 49.6% | 114.2% | -4.1% | 4.2% | 11.2% | |
EBITDA | 3,061.5 | 763.0 | 2,395.5 | 2,765.5 | 3,168.8 | 2,537.0 | 2,998.6 | 6,205.1 | 5,784.1 | 5,804.2 | |
EBITDA % Chg. | 14.4% | -75.1% | 213.9% | 15.4% | 14.6% | -19.9% | 18.2% | 106.9% | -6.8% | -24.1% | |
EBITDA Margin | 23.2% | 5.5% | 17.0% | 20.5% | 23.0% | 15.5% | 11.7% | 24.9% | 20.8% | 19.9% | |
EBITDA Margin % Chg. | 5.3% | -76.3% | 208.8% | 20.5% | 12.1% | -32.4% | -24.7% | 113.0% | -16.5% | -31.1% |